Fax: (202) 444-9429.
Targeted therapy in prostate cancer—Are we our own worst enemy?†
Article first published online: 8 SEP 2008
Copyright © 2008 American Cancer Society
Volume 113, Issue 9, pages 2376–2378, 1 November 2008
How to Cite
Dawson, N. A. (2008), Targeted therapy in prostate cancer—Are we our own worst enemy?. Cancer, 113: 2376–2378. doi: 10.1002/cncr.23865
See referenced original article on pages 2478–87, this issue.
- Issue published online: 17 OCT 2008
- Article first published online: 8 SEP 2008
- Manuscript Accepted: 18 JUN 2008
- Manuscript Received: 16 JUN 2008
Targeted therapies are being assessed in castrate-resistant prostate cancer, but their development is slow, and the correct targets are not always clear. Given the propensity for prostate cancer to metastasize to bone, therapies that target the bone microenvironment are a logical choice.